'Dangerous Drugs & Medical Devices' Category
By Simmons Hanly Conroy | March 17, 2023
What to Know About the February 2023 Updates to Philips CPAP Recall
The United States Food and Drug Administration (FDA) announced a recall of reworked Philips Respironics machines due to silicone foam deterioration that, if inhaled, could cause cancer, organ damage and even death.… Read More
By Simmons Hanly Conroy | March 18, 2022
In the News: $26 Billion in Funding to Go to Communities Around the Country After Johnson & Johnson, Drug Distributors Finalize Opioid Settlement
In late February, the nation’s three largest drug distributors — AmerisourceBergen, Cardinal Health and McKesson — and drugmaker Johnson & Johnson agreed to finalize a $26 billion opioid settlement with states and… Read More
By Simmons Hanly Conroy | March 18, 2022
FDA Orders Philips Respironics to Improve Its Communications Regarding June 2021 Recall of Sleep Apnea Machines
On March 10, the U.S. Food and Drug Administration (FDA) issued an order to Philips Respironics — maker of ventilators, CPAP and BiPAP machines — to notify all patients about their recall… Read More
By Simmons Hanly Conroy | May 22, 2020
Cosmetic Talc Allegations Involving Mesothelioma Continue to Rise as J&J Stops Selling Talc Baby Powder Product
Partner James Kramer weighs in on talc litigation during Perrin webinar Talcum powder and other talc-based products sit at the heart of over 9,000 lawsuits currently awaiting trial. But how did it… Read More
By Simmons Hanly Conroy | August 31, 2019
In Landmark Trial, Johnson & Johnson Ordered to Pay $572 Million for Its Role in Opioid Epidemic
In a landmark judgement, Oklahoma judge Thad Balkman ruled on Monday, Aug. 26, that Johnson & Johnson is liable for playing a large role in sparking the state’s opioid crisis through its… Read More
By Simmons Hanly Conroy | November 22, 2016
FDA Mandates Boxed Warning, Patient Checklist for Essure
The U.S. Food and Drug Administration (FDA) recommended on Nov. 15 a boxed warning and a patient checklist that highlights possible adverse events associated with the use of Essure, Bayer’s permanent contraception… Read More
By Simmons Hanly Conroy | October 26, 2015
The History of Risperdal in the Pharmaceutical Marketplace
Also known by the generic name risperidone, Risperdal is a powerful, anti-psychotic medication prescribed to treat schizophrenia, autism and bipolar disorders in adults. Its manufacturer, Johnson & Johnson (J&J), has recently been making… Read More
By Simmons Hanly Conroy | February 5, 2014
Simmons Hanly Conroy Files First Testosterone Treatment Lawsuits, Bloomberg Reports
Yesterday, attorneys at the firm filed the first testosterone treatment lawsuit on behalf of five men against Abbott Laboratoes and AbbVie, Inc. The men range in age from 50 to 63 and… Read More
By Simmons Hanly Conroy | June 7, 2013
DA Approves Liptruzet – Merck’s Combination of Zetia and Lipitor
The Food and Drug Administration recently approved a new cholesterol-lowering medication called Liptruzet. This drug combines two already existing medications. The first, Zetia, goes by the generic name ezetimibe and works by… Read More
By Simmons Hanly Conroy | December 23, 2010
Looking Back, Moving Forward
For me, December and the holiday season has always been a time to reflect on the past year. A time to remember the challenges we’ve overcome; the projects we’ve spearheaded; and the… Read More
